XW4-26078-88230
4 vaccinations
9 coded responses
21 check-ins
9 free-text entries
2 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 271 / NC
- Registered
- 2021-04-11
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
B3K-25743-36511
Child or adolescent in my care · Male · 2022-06-27
Timeline
-
2021-03-21
Dose 1 — Pfizer-BioNTech
-
2021-04-11
Registered in v-safe
-
2021-04-11
Dose 2 — Pfizer-BioNTech
- 2021-04-11
-
2021-04-12
Survey response — days 1–6 daily, dose 2MedDRA: Hyperhidrosis — Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tiredness, Diarrhea · Be unable to work, Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-04-13
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Fever · Headache, Fatigue or tirednessAdult check-in
-
2021-04-14
Survey response — days 1–6 daily, dose 2MedDRA: Intermenstrual bleeding — Feeling: Good · Site: PainMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-04-15
- 2021-04-16
- 2021-04-17
- 2021-04-18
-
2021-04-25
Survey response — 14 day, dose 2MedDRA: Injection site rash — Feeling: GoodMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-05-02
- 2021-05-09
-
2021-05-16
Survey response — 35 day, dose 2MedDRA: Fatigue, Oropharyngeal pain, Pain, Respiratory tract congestion — Feeling: Fair · Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
-
2021-05-23
Survey response — 42 day, dose 2MedDRA: Cough, Fatigue, Myalgia, Nasal congestion, Sinus pain — Feeling: Good · Be unable to work, Be unable to do your normal daily activitiesMedDRA releases: 2021-09,2023-04,2024-11 · check-in answers available
- 2021-07-11
-
2021-10-10
Survey response — 6 month, dose 2MedDRA: Aphonia, Cough, Fatigue, Malaise, Pyrexia, Respiratory tract congestion, Rhinorrhoea, SARS-CoV-2 test negative — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Outpatient clinic or urgent care clinic visitMedDRA releases: 2024-11 · check-in answers available
-
2021-10-10
Report sent to call center — 6 month, dose 2Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prTelehealth, virtual health, or email health consultation · Outpatient clinic or urgent care clinic visit · 1 call case(s)
-
2021-10-20
Dose 3 — Pfizer-BioNTech
- 2021-11-01
-
2022-04-11
Survey response — 12 month, dose 2MedDRA: COVID-19, Fatigue, Headache, Mobility decreased, Nasopharyngitis, Oropharyngeal pain, Productive cough, Respiratory tract congestion, Secretion discharge — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activitiesMedDRA releases: 2024-11 · check-in answers available
-
2022-09-07
Dose 4 — Pfizer-BioNTech
- 2022-10-06
- 2022-10-12
-
2022-10-19
Survey response — 42 day, dose 4MedDRA: Blood pressure increased, Office visit, Pregnancy — Feeling: Good · Get care from a doctor or other healthcare professionalMedDRA releases: 2024-11 · check-in answers available
-
2022-10-19
Report sent to call center — 42 day, dose 4Get care from a doctor or other healthcare professional1 call case(s)
-
2022-10-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-10-20
Call successfulNot applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill
-
2022-12-07
Survey response — 3 month, dose 4MedDRA: Cough, Nasal congestion, Oropharyngeal pain — Feeling: FairMedDRA releases: 2024-11 · check-in answers available
- 2023-03-10
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-21 | Pfizer-BioNTech | |
| 2 | 2021-04-11 | Pfizer-BioNTech | |
| 3 | 2021-10-20 | Pfizer-BioNTech | No |
| 4 | 2022-09-07 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2021-10-10 | Successful 2022-10-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
| 2022-10-19 | Successful 2022-10-20 |
Not applicable – Participant does not believe symptoms are related to vaccine and does not wish to fill |
Free text
Release 7
Systemic reaction (other): Sweating
Systemic reaction (other): Yesterday (after taking my survey) I had menstrual spotting
Symptoms: Mild rash on the arm where I received the injection
Release 8
Symptoms: Sore throat, congestion, body aches, tired
Symptoms: Fatigue, muscle aches, nasal congestion, cough, sinus pain.
Release 10
Symptoms: I've been sick for the past 3 weeks. I took 2 home covid tests, both negative. Early on I had a fever for 2-3 days, and lost my voice. Throughout I've had a cough, runny nose, chest congestion, and fatigue.
Release 11
Symptoms: I had Covid beginning March 16. I was exhausted in bed for 1.5 weeks. Other than the exhaustion I had mostly head cold symptoms (sore throat, congestion, coughing up mucus, headache).
Release 12
Symptoms: Blood pressure higher than usual in last few weeks of pregnancy
Healthcare visit (other): Obgyn
Symptoms: Nasal congestion, sore throat, occasional cough
Free-text releases are not linked to a specific survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| HCVO | Office visit | · | · | ✓ |
| SD | Aphonia | · | · | ✓ |
| SD | Blood pressure increased | · | · | ✓ |
| SD | Cough | ✓ | ✓ | ✓ |
| SD | COVID-19 | · | · | ✓ |
| SD | Fatigue | ✓ | ✓ | ✓ |
| SD | Headache | · | · | ✓ |
| SD | Injection site rash | ✓ | ✓ | ✓ |
| SD | Malaise | · | · | ✓ |
| SD | Mobility decreased | · | · | ✓ |
| SD | Myalgia | ✓ | ✓ | ✓ |
| SD | Nasal congestion | ✓ | ✓ | ✓ |
| SD | Nasopharyngitis | · | · | ✓ |
| SD | Oropharyngeal pain | ✓ | ✓ | ✓ |
| SD | Pain | ✓ | ✓ | ✓ |
| SD | Pregnancy | · | · | ✓ |
| SD | Productive cough | · | · | ✓ |
| SD | Pyrexia | · | · | ✓ |
| SD | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | SARS-CoV-2 test negative | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
| SD | Sinus pain | ✓ | ✓ | ✓ |
| SRO | Hyperhidrosis | ✓ | ✓ | ✓ |
| SRO | Intermenstrual bleeding | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release